If the makers of branded drugs are unable to settle with their generic rivals, life becomes far more difficult.

FORBES: Magazine Article

There were concerns that, if granted, a patent could threaten access to cheap generic versions of life-saving drugs in poorer countries.

BBC: Novartis India case: Campaigners hail patent rejection